# Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders

> **NCT00845988** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 28 (actual)

## Conditions studied

- Bipolar Disorders
- Metabolic Complication

## Interventions

- **DRUG:** aripiprazole

## Key facts

- **NCT ID:** NCT00845988
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2013-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00845988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00845988, "Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00845988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*